Latest Administration News

Page 11 of 248
PARKD has secured two early-stage contracts, added Symal as its exclusive partner in Victoria and South Australia, and lifted pro forma cash to about A$850,000 through a strategic placement. The progress comes against a sharp liquidity squeeze, with just A$53,000 in cash at 30 September and funding equivalent to 0.21 quarters before the raise.
Victor Sage
Victor Sage
30 Oct 2026
Oakridge International reported a $267,000 operating cash outflow for the September quarter, leaving $343,000 in cash and an estimated 1.28 quarters of funding. The healthcare technology company expects collections and customer orders to improve cash flow, while evaluating additional funding and continuing to manage a potential historical claim from Teko International.
Victor Sage
Victor Sage
30 Oct 2026
Australian Bond Exchange generated $1.68 million in positive operating cash flow in Q1 FY27, lifting cash to $1.49 million while repaying $436,000 of borrowings. The result strengthens its balance sheet, though the quarter’s cash inflows included $263,000 in government grants or tax incentives and $150,000 of interest received.
Victor Sage
Victor Sage
30 Oct 2026
Syntara has reported statistically significant exploratory results for its Parkinson’s-related drug SNT-4728, while advancing blood-cancer and scar studies. The quarter also brought A$4.7 million in R&D funding, but the liquidation of a former buyer threatens a facility relocation and recovery of about A$0.6 million.
Ada Torres
Ada Torres
30 Oct 2026
Fulcrum Lithium has delivered a 10.7 million tonne lithium carbonate equivalent resource at Alkali Flats, while advancing acid-free extraction tests and securing approval to drill Dry Canyon. The progress comes with only A$875,000 in cash and no stated plan to raise more funds.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Norfolk Metals has extended the deadline for its proposed Ciclón copper acquisition to 31 December and reduced the minimum capital raising requirement to A$75 million. The deal remains dependent on funding, ASX reinstatement and other conditions, while the company reported just $155,000 in quarter-end cash before drawing a related-party loan.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Zelira Therapeutics has only A$47,000 in cash after a quarterly operating outflow of A$56,000, while the proposed US$32.98 million HOPE 1 fundraising remains unclosed. The company says the funds are needed for an FDA application and Phase 1 trial, as its ASX quotation suspension continues.
Victor Sage
Victor Sage
30 Oct 2026
Invex Therapeutics has paired its proposed acquisition of Rekover Therapeutics with a $10 million equity raising to fund a Phase 2a multiple sclerosis study and its existing Exenatide programs. The biotech ended September with A$3.59 million in cash, with shareholder approval still required for the larger part of the transaction.
Ada Torres
Ada Torres
30 Oct 2026
Rubix Resources has reported encouraging copper exploration signals at Paperbark and stronger prospectivity at Redbeds, but ended the September quarter with just A$6,000 in cash. The company estimates it has 0.05 quarters of funding available and says it will need to raise more capital to continue operations.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Flynn Gold has advanced drilling, metallurgy and a potential processing route for its Tasmanian gold assets, while a completed A$1.5 million rights issue addresses a sharp quarter-end funding gap. The company held just A$409,000 in cash at 30 September, equivalent to 0.4 quarters of funding on its reported spending rate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Taruga Minerals has mobilised its first diamond drill rig at the Weioko Gold Deposit since 2009, while preliminary oxide testwork returned gold recoveries of up to 96.27%. The results are encouraging, but the company’s cash position remains tight before a post-quarter option exercise raised A$1.5 million.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Epsilon Healthcare delivered record September-quarter customer receipts of A$3.9 million, while nine-month revenue reached A$11.5 million. The growth story is strengthening, but cash fell to A$997,000 and quarterly operating cash flow remained negative.
Ada Torres
Ada Torres
30 Oct 2026

Browse the archive

Full archive